Between January 1991 and December 1994, 132 uncemented total hip arthroplasties (THA) were performed on 125 patients over 65 years of age; of which 102 arthroplasties, performed in 90 patients, were followed for at least 4 years. One revision was necessary following fracture of an acetabular component secondary to trauma. The post-operative Harris hip score (HHS) ranged from 87 to 99. Radiologically there were no signs of subsidence of more than 3 mm, nor of osteolysis. Five patients experienced thigh pain. Based on the clinical and radiological results, uncemented total hip arthroplasties can give satisfactory function in elderly patients.Résumé Entre Janvier 1991 et Décembre 1994, 132 arthroplasties primaires totales de hanche sans ciment ont été faites chez 125 patients, avec comme critèere d' inclusion l' âge au dessus de 65 ans. Nous avons révisé les résultats de 102 de ces arthroplasties chez 90 patients. La durée minimum de surveillance médicale était de 4 ans (moyenne: 64 mois, extrémes: 48-96 mois). Ancune revision n' a été faite jusqu' à maintenant à cause d'une implantation déficitaire. Une revision (1%) a été nécessaire suite à une rupture traumatique du constituant acétabulaire. Tenant compte de la dermière consultation, le score-hanche Harris allait de 87 à 99. L' évaluation radiologique n' a révéle aucune signe de subsidence majeure (plus de 3 mm) ni d'ostéolyse. Toutes les implantations demeurent stable. Il reste une incidence de 5.3% de douleur sciatique. Se fondant sur ces résultats excellents cliniques et radiographiques on peut confirmer l' évolut-ion satisfaisante des arthroplasties totales de hanche sans ciment dans le contexte d' ostéoporose.

No abstract

Background Osteoarthritis (OA) represents a leading cause of disability with limited data available for the Greek patients. Objectives To evaluate the impact of moderate to severe symptomatic hip/knee OA under treatment on physical performance and quality of life. Methods A non-interventional, cross-sectional, epidemiological study of patients with moderate/severe OA, recruited in a single visit from 9 expert sites in Athens, Greece. Assessments were based on commonly used outcome scales: the Hip disability and Osteoarthritis Outcome Score (HOOS), the Knee Injury and Osteoarthritis Outcome Score (KOOS) and the EuroQol-5-Dimensions 3-levels questionnaire (EQ-5D-3L). Results One hundred sixty-four patients were included in the analysis. Most of the patients were females (78.7%), with a mean age of 70.5 ± 10.2 years. Comorbidities were reported by 87.2% of patients with hypertension being the most frequently reported (53.7%), followed by dyslipidemia (31.1%), obesity (24.4%) and diabetes mellitus (23.2%). Paracetamol was the most common treatment (96%), followed by NSAIDs (75%), opioids (50%) and locally applied medications (42.7%). Both hip and knee OA patients showed substantial deterioration in health-related quality of life (QoL) and health status as reflected by the HOOS/KOOS (Function in sport and recreation was the most impaired subscale, followed by Hip- or Knee-related QoL). The mean EQ-5D-3L index score was 0.396 ± 0.319 and the mean EQ-VAS score was 52.1 ± 1.9. When compared indirectly to the local population norms our OA population had worse QoL indices. Conclusion Our findings suggest the functional disability and impaired QoL of Greek patients with moderate/severe hip/knee OA under treatment emphasizing the need for novel treatments that will reduce the burden of the disease.